Heartflow Inc
NASDAQ:HTFL
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Intrinsic Value
The intrinsic value of Heartflow Inc (HTFL) under the Base Case is 7.75 USD per share. Compared with the current market price of 44.63 USD, the stock appears Overvalued by 83% .
The intrinsic value is calculated using the DCF method. Net margin recovers from -66% last year to 12% by 2031. Revenue grows about 25% a year over the next five years.
Do our valuations actually work? See backtest results .
Fundamental Analysis
What Heartflow Does
Heartflow is a medical technology company that helps doctors look for coronary artery disease using heart CT scans. Its core product is software that turns a standard coronary CT angiogram into a detailed 3D model of the patient’s arteries and gives doctors more information about blood flow and plaque. Instead of building devices or drugs, Heartflow sells analysis services and software that sit between the imaging scan and the treatment decision.
- Headquarters
- United States of America US
- Employees
- 843
- IPO date
- Aug 8, 2025
Balance Sheet
Recent Events
Latest Earnings Call
HeartFlow reported accelerating revenue growth and stronger momentum across Plaque and FFRCT, while raising its full-year outlook.
Open the earnings call- EPS
- −$0.12
- Expected
- −$0.18
- Surprise
- +33.3%
- Stock, next trading day
- −19.1%
Heartflow insiders are selling more than usual
Insiders sell for many reasons, such as taxes or planned sales; purchases are rarer.
Past 12 months
Continue HTFL Research
Decided on Heartflow? Get an email when HTFL reaches the price you’d buy at. Free with an account.
What is the Intrinsic Value of one HTFL stock?
The intrinsic value for Heartflow Inc (HTFL) under the Base Case is 7.75 USD.
Is HTFL stock undervalued or overvalued?
Compared with the current market price of 44.63 USD, the stock appears Overvalued by 83% .